{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:10Z","timestamp":1792799410654,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012309","name":"Royal Golden Jubilee (RGJ) Ph.D. Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.08.021","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T17:55:23Z","timestamp":1597946123000},"page":"6814-6825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Nanodelivery system enhances the immunogenicity of dengue-2 nonstructural protein 1, DENV-2 NS1"],"prefix":"10.1016","volume":"38","author":[{"given":"Tuksin","family":"Jearanaiwitayakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panya","family":"Sunintaboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runglawan","family":"Chawengkittikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitra","family":"Limthongkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panuwat","family":"Midoeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saradee","family":"warit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukathida","family":"Ubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.021_b0005","unstructured":"WHO. Dengue Fact Sheet, 2019 [accessed Date Accessed 2019]. http:\/\/origin.searo.who.int\/entity\/vector_borne_tropical_diseases\/data\/data_factsheet\/en\/."},{"key":"10.1016\/j.vaccine.2020.08.021_b0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1473-3099(16)00146-8","article-title":"The global economic burden of dengue: a systematic analysis","volume":"16","author":"Shepard","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.021_b0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/14760584.2016.1189331","article-title":"The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection","volume":"15","author":"Pitisuttithum","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.08.021_b0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/infdis\/jiv082","article-title":"Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy Flavivirus-Naive Adults","volume":"212","author":"Kirkpatrick","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.021_b0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.08.021_b0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.12688\/wellcomeopenres.15507.1","article-title":"Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines","volume":"4","author":"Flasche","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.vaccine.2020.08.021_b0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2020.08.021_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0042-6822(88)90408-4","article-title":"Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer","volume":"162","author":"Winkler","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.021_b0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2016.02.014","article-title":"The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design","volume":"130","author":"Watterson","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2020.08.021_b0050","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/343813","article-title":"High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever","volume":"186","author":"Libraty","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.021_b0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jinf.2011.11.023","article-title":"Dengue virus nonstructural protein NS1 binds to prothrombin\/thrombin and inhibits prothrombin activation","volume":"64","author":"Lin","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.08.021_b0060","doi-asserted-by":"crossref","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2020.08.021_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005738","article-title":"Dengue Virus NS1 Disrupts the Endothelial Glycocalyx Leading to Hyperpermeability","volume":"12","author":"Puerta-Guardo","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.08.021_b0070","doi-asserted-by":"crossref","first-page":"304ra142","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2020.08.021_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092495","article-title":"Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1","volume":"9","author":"Wan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.08.021_b0080","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1038\/s41598-017-07308-3","article-title":"Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection","volume":"7","author":"Lai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.08.021_b0085","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.4049\/jimmunol.1601523","article-title":"Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection","volume":"199","author":"Wan","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.vaccine.2011.12.034","article-title":"Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant","volume":"30","author":"Amorim","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.021_b0095","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4049\/jimmunol.1801323","article-title":"Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses","volume":"202","author":"Espinosa","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0100","doi-asserted-by":"crossref","first-page":"29201","DOI":"10.1038\/srep29201","article-title":"Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses","volume":"6","author":"Flipse","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.08.021_b0105","article-title":"Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate","author":"Sharma","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.021_b0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3181\/0805-RM-147","article-title":"Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies","volume":"234","author":"Cheng","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.vaccine.2020.08.021_b0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.169.2.657","article-title":"Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide","volume":"169","author":"Lin","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0120","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1538-7836.2007.02754.x","article-title":"Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice","volume":"5","author":"Sun","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vaccine.2020.08.021_b0125","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.0800672","article-title":"Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency","volume":"183","author":"Chen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0135","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle Vaccines Against Infectious Diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0140","doi-asserted-by":"crossref","unstructured":"C. Choi, J.-P. Nam, and J.-W. Nah. Application of chitosan and chitosan derivatives as biomaterials. Journal of Industrial and Engineering Chemistry 2016;33:1-10. http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jiec.2015.10.028.","DOI":"10.1016\/j.jiec.2015.10.028"},{"key":"10.1016\/j.vaccine.2020.08.021_b0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1348-0421.12497","article-title":"EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model","volume":"61","author":"Nantachit","year":"2017","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0150","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fmicb.2019.01113","article-title":"Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice","volume":"10","author":"Wang","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0952-7915(00)00180-1","article-title":"The cell biology of antigen presentation in dendritic cells","volume":"13","author":"Thery","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0160","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2003-12-4392","article-title":"Manipulating dendritic cell biology for the active immunotherapy of cancer","volume":"104","author":"O'Neill","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2020.08.021_b0165","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/IAI.67.6.2713-2719.1999","article-title":"Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host","volume":"67","author":"C\u00eatre","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.08.021_b0170","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/s41598-018-21039-z","article-title":"Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection","volume":"8","author":"Firacative","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.08.021_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.vaccine.2020.08.021_b0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2020.08.021_b0185","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","author":"Arango Duque","year":"20145491","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0190","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.4049\/jimmunol.168.12.6165","article-title":"Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing\/maintaining IL-12 receptor beta 2 expression","volume":"168","author":"Smeltz","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0195","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1080\/15384101.2015.1093703","article-title":"IL-12 induced the generation of IL-21- and IFN-gamma-co-expressing poly-functional CD4+ T cells from human naive CD4+ T cells","volume":"14","author":"Yu","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.vaccine.2020.08.021_b0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.it.2011.01.004","article-title":"Cytokines and the inception of CD8 T cell responses","volume":"32","author":"Cox","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.08.021_b0215","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1016\/j.vaccine.2012.06.035","article-title":"Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics","volume":"30","author":"Tafaghodi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.021_b0220","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2010.06.121","article-title":"Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen","volume":"28","author":"Slutter","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.021_b0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fimmu.2018.00562","article-title":"Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax","volume":"9","author":"Malik","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0230","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.2147\/IJN.S149774","article-title":"Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection","volume":"12","author":"Abkar","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2020.08.021_b0235","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.vaccine.2018.02.072","article-title":"Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model","volume":"36","author":"Dabaghian","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.021_b0240","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.1038\/s41598-017-15039-8","article-title":"A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model","volume":"7","author":"Brault","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.08.021_b0245","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1128\/JVI.00879-07","article-title":"Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells","volume":"81","author":"Chung","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0250","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/infdis\/jir012","article-title":"Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection","volume":"203","author":"Hatch","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.021_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001449","article-title":"IFN-gamma production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner","volume":"5","author":"Fagundes","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.08.021_b0260","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/hum.2008.011","article-title":"Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes","volume":"19","author":"Gao","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2020.08.021_b0265","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3389\/fimmu.2019.01522","article-title":"T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification","volume":"10","author":"Pinto","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.08.021_b0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjug Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:06Z","timestamp":1759402086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":54,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20310525"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanodelivery system enhances the immunogenicity of dengue-2 nonstructural protein 1, DENV-2 NS1","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}